Analysts are weighing in on regenerative-medicine company Osiris Therapeutics, Inc. (NASDAQ:OSIR) and internet-communications firm magicJack VocalTec Ltd (NASDAQ:CALL), as shares of both companies fell sharply today due to various …
Analysts are weighing in on biotech companies Pacific Biosciences of California (NASDAQ:PACB) and Osiris Therapeutics, Inc. (NASDAQ:OSIR), as shares of both companies fell sharply today …
Analysts are weighing in on the biopharmaceutical companies Cytori Therapeutics Inc (NASDAQ:CYTX) and Osiris Therapeutics, Inc. (NASDAQ:OSIR), as shares of both companies fell …
In a research report released Tuesday, Brean Capital analyst Jason Wittes downgraded shares of Osiris Therapeutics, Inc. (NASDAQ:OSIR) from a Hold to a Sell rating, …
In a research report published Friday, Brean Capital analyst Difei Yang maintained a Buy rating on Osiris Therapeutics, Inc. (NASDAQ:OSIR) with a $19.
In a research report sent to investors today, Brean Capital analyst Difei Yang maintained a Buy rating on Osiris Therapeutics (NASDAQ:OSIR) with a …
Osiris Therapeutics (NASDAQ:OSIR) stem cells aren’t the big source of buzz they were just a few years ago. We have moved on to …
